| Metronomic chemotherapy: new rationale for new directions E Pasquier, M Kavallaris, N André Nature reviews Clinical oncology 7 (8), 455-465, 2010 | 749 | 2010 |
| Risk stratification of childhood medulloblastoma in the molecular era: the current consensus V Ramaswamy, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz, M Kool, ... Acta neuropathologica 131, 821-831, 2016 | 685 | 2016 |
| Metronomics: towards personalized chemotherapy? N André, M Carré, E Pasquier Nature reviews Clinical oncology 11 (7), 413-431, 2014 | 343 | 2014 |
| Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel M Carreá, N Andreá, G Carles, H Borghi, L Brichese, C Briand, D Braguer Journal of Biological Chemistry 277 (37), 33664-33669, 2002 | 321 | 2002 |
| Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment E Pasquier, J Ciccolini, M Carre, S Giacometti, R Fanciullino, C Pouchy, ... Oncotarget 2 (10), 797-809, 2011 | 273 | 2011 |
| Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor F Bourdeaut, D Lequin, L Brugieres, S Reynaud, C Dufour, F Doz, ... Clinical Cancer Research 17 (1), 31-38, 2011 | 244 | 2011 |
| Computational oncology—mathematical modelling of drug regimens for precision medicine D Barbolosi, J Ciccolini, B Lacarelle, F Barlési, N André Nature reviews Clinical oncology 13 (4), 242-254, 2016 | 235 | 2016 |
| Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells N André, D Braguer, G Brasseur, A Gonçalves, D Lemesle-Meunier, ... Cancer research 60 (19), 5349-5353, 2000 | 226 | 2000 |
| Mathematical modeling of cancer immunotherapy and its synergy with radiotherapy R Serre, S Benzekry, L Padovani, C Meille, N André, J Ciccolini, F Barlesi, ... Cancer research 76 (17), 4931-4940, 2016 | 189 | 2016 |
| Has the time come for metronomics in low-income and middle-income countries? N André, S Banavali, Y Snihur, E Pasquier The Lancet Oncology 14 (6), e239-e248, 2013 | 188 | 2013 |
| Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study C Dufour, A Beaugrand, MC Le Deley, F Bourdeaut, N André, P Leblond, ... Cancer 118 (15), 3812-3821, 2012 | 188 | 2012 |
| β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma E Pasquier, J Street, C Pouchy, M Carre, AJ Gifford, J Murray, MD Norris, ... British journal of cancer 108 (12), 2485-2494, 2013 | 186 | 2013 |
| SKIV2L mutations cause syndromic diarrhea, or trichohepatoenteric syndrome A Fabre, B Charroux, C Martinez-Vinson, B Roquelaure, E Odul, E Sayar, ... The American Journal of Human Genetics 90 (4), 689-692, 2012 | 185 | 2012 |
| Neurocognitive function after radiotherapy for paediatric brain tumours L Padovani, N André, LS Constine, X Muracciole Nature Reviews Neurology 8 (10), 578-588, 2012 | 171 | 2012 |
| DICER1 Mutations in embryonal rhabdomyosarcomas from children with and without familial PPB‐tumor predisposition syndrome L Doros, J Yang, L Dehner, CT Rossi, K Skiver, JA Jarzembowski, ... Pediatric blood & cancer 59 (3), 558-560, 2012 | 169 | 2012 |
| Targeting microtubules to inhibit angiogenesis and disrupt tumour vasculature: implications for cancer treatment E Pasquier, N Andre, D Braguer Current cancer drug targets 7 (6), 566-581, 2007 | 165 | 2007 |
| Paclitaxel targets mitochondria upstream of caspase activation in intact human neuroblastoma cells N André, M Carré, G Brasseur, B Pourroy, H Kovacic, C Briand, D Braguer FEBS letters 532 (1-2), 256-260, 2002 | 157 | 2002 |
| Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies J Ciccolini, L Dahan, N André, A Evrard, M Duluc, A Blesius, C Yang, ... Journal of clinical oncology 28 (1), 160-165, 2010 | 151 | 2010 |
| Effective management of advanced angiosarcoma by the synergistic combination of propranolol and vinblastine-based metronomic chemotherapy: a bench to bedside study E Pasquier, N André, J Street, A Chougule, B Rekhi, J Ghosh, DSJ Philip, ... EBioMedicine 6, 87-95, 2016 | 138 | 2016 |
| Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study S Mukkada, N Bhakta, GL Chantada, Y Chen, Y Vedaraju, L Faughnan, ... The Lancet Oncology 22 (10), 1416-1426, 2021 | 130 | 2021 |
joseph ciccoliniAix Marseille Univ (AMU, SMARTc COMPO CRCM) and Assistance Publique Hôpitaux de Marseille (APHM)Email được xác minh tại univ-amu.fr